NZ228845A - Tablet for the continuous osmotic dispensing of metoprolol consisting of a core, an inner layer surrounding the core and an outer layer impermeable to metoprolol - Google Patents

Tablet for the continuous osmotic dispensing of metoprolol consisting of a core, an inner layer surrounding the core and an outer layer impermeable to metoprolol

Info

Publication number
NZ228845A
NZ228845A NZ228845A NZ22884589A NZ228845A NZ 228845 A NZ228845 A NZ 228845A NZ 228845 A NZ228845 A NZ 228845A NZ 22884589 A NZ22884589 A NZ 22884589A NZ 228845 A NZ228845 A NZ 228845A
Authority
NZ
New Zealand
Prior art keywords
metoprolol
core
tablet
outer layer
inner layer
Prior art date
Application number
NZ228845A
Other languages
English (en)
Inventor
Shah
B Shailesh
Arun Dattatreya Koparkar
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ228845A publication Critical patent/NZ228845A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • External Artificial Organs (AREA)
NZ228845A 1988-04-25 1989-04-21 Tablet for the continuous osmotic dispensing of metoprolol consisting of a core, an inner layer surrounding the core and an outer layer impermeable to metoprolol NZ228845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/185,564 US4892739A (en) 1988-04-25 1988-04-25 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties

Publications (1)

Publication Number Publication Date
NZ228845A true NZ228845A (en) 1990-10-26

Family

ID=22681522

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ228845A NZ228845A (en) 1988-04-25 1989-04-21 Tablet for the continuous osmotic dispensing of metoprolol consisting of a core, an inner layer surrounding the core and an outer layer impermeable to metoprolol

Country Status (22)

Country Link
US (1) US4892739A (enExample)
EP (1) EP0339506B1 (enExample)
JP (1) JP2750150B2 (enExample)
KR (1) KR0125935B1 (enExample)
AT (1) ATE75939T1 (enExample)
AU (1) AU618083B2 (enExample)
CA (1) CA1334382C (enExample)
DD (1) DD288093A5 (enExample)
DE (1) DE58901373D1 (enExample)
DK (1) DK175232B1 (enExample)
ES (1) ES2031302T3 (enExample)
FI (1) FI90203C (enExample)
GR (1) GR3005399T3 (enExample)
HU (1) HU201469B (enExample)
IE (1) IE61223B1 (enExample)
IL (1) IL90019A (enExample)
MX (1) MX15754A (enExample)
NO (1) NO175186C (enExample)
NZ (1) NZ228845A (enExample)
PH (1) PH27150A (enExample)
PT (1) PT90341B (enExample)
ZA (1) ZA892998B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
JP2004531463A (ja) 2000-11-03 2004-10-14 アンドルクス ラブス，エルエルシー 徐放メトホルミン組成物
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
ES2529180T3 (es) 2002-09-20 2015-02-17 Andrx Labs Llc Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
AU2003903507A0 (en) * 2003-07-08 2003-07-24 U. S. Filter Wastewater Group, Inc. Membrane post-treatment
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
CA2556922C (en) * 2004-03-05 2012-05-15 Mcneil-Ppc, Inc. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
WO2006002479A1 (en) * 2004-07-05 2006-01-12 U.S. Filter Wastewater Group, Inc. Hydrophilic membranes
IL166114A0 (en) * 2005-01-03 2006-01-15 Calcident Active Ltd Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
CN102670555A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 富马酸美托洛尔渗透泵控释片
CN102670539A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 琥珀酸美托洛尔渗透泵控释片
EP2895257A1 (en) 2012-09-14 2015-07-22 Evoqua Water Technologies LLC A polymer blend for membranes
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3322511B1 (en) 2015-07-14 2022-09-07 Rohm & Haas Electronic Materials Singapore Pte. Ltd Aeration device for filtration system
US20210283046A1 (en) * 2018-07-24 2021-09-16 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
WO2022060909A1 (en) * 2020-09-15 2022-03-24 Synagile Corporation Devices and methods for continuous extrusion of a drug into the mouth

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3778662D1 (de) * 1986-11-14 1992-06-04 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.

Also Published As

Publication number Publication date
DD288093A5 (de) 1991-03-21
JPH029815A (ja) 1990-01-12
ES2031302T3 (es) 1992-12-01
NO175186C (no) 1994-09-14
PT90341A (pt) 1989-11-10
FI90203C (fi) 1994-01-10
ATE75939T1 (de) 1992-05-15
GR3005399T3 (enExample) 1993-05-24
CA1334382C (en) 1995-02-14
FI891921A7 (fi) 1989-10-26
ZA892998B (en) 1989-12-27
MX15754A (es) 1994-01-31
DK175232B1 (da) 2004-07-19
HUT50625A (en) 1990-03-28
KR900015734A (ko) 1990-11-10
PH27150A (en) 1993-04-02
NO891680D0 (no) 1989-04-24
JP2750150B2 (ja) 1998-05-13
US4892739A (en) 1990-01-09
IE61223B1 (en) 1994-10-19
NO175186B (enExample) 1994-06-06
DK196189A (da) 1989-10-26
EP0339506A1 (de) 1989-11-02
AU618083B2 (en) 1991-12-12
FI90203B (fi) 1993-09-30
KR0125935B1 (ko) 1997-12-26
IL90019A (en) 1994-04-12
HU201469B (en) 1990-11-28
NO891680L (no) 1989-10-26
AU3268789A (en) 1989-10-26
EP0339506B1 (de) 1992-05-13
FI891921A0 (fi) 1989-04-21
DE58901373D1 (de) 1992-06-17
IL90019A0 (en) 1989-12-15
PT90341B (pt) 1994-08-31
IE891316L (en) 1989-10-25
DK196189D0 (da) 1989-04-24

Similar Documents

Publication Publication Date Title
GR3005399T3 (enExample)
AU1534699A (en) Osmotic dosage form comprising first and second coats
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
PH25905A (en) A controlled release pharmaceutical dosage form
EP1078628A3 (en) Multiple unit tableted dosage form
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
ATE286725T1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AR241676A1 (es) Suministrador de agente beneficioso a un ambiente de uso.
GB0007419D0 (en) Composition
EP0091964A4 (en) BASIC COMPOSITION FOR THE PREPARATION OF DRUGS FOR EXTERNAL APPLICATION, MEDICINAL COMPOSITION FOR EXTERNAL APPLICATION, AND METHOD FOR ACCELERATING THE PERCUTANEOUS ABSORPTION OF A MEDICINAL AGENT.
AU6740687A (en) Pseudoephedrine, brompheniramin therapy
DE69401972D1 (de) Feste Arzneimitteldosierungsform und Methode zur Verminderung des Abriebs
PL236145A1 (enExample)
AU536527B2 (en) 10-substituted 5-cyanomethylene-di-benzo(a,d)-cyclo-heptenes
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
IT1244037B (it) Forma farmaceutica a rilascio selettivo nel colon
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
JO1880B1 (en) Format 1 for multi-unit calibration discs
ZA817788B (en) Imidazole derivatives,their preparation,and pharmaceutical formulation thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)